Enlivex (ENLV) Revenue Growth (1y) (2023 - 2025)

Enlivex (ENLV) Revenue Growth (1y) (2023 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	12.45%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	16.73%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.71%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	2.11%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	29.63%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	66.86%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-99.97%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	296.11%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	16.50%
10	Enlivex	4.51 Mn	-1.25 Mn	-	-

Download Data